The issue has been subscribed 33% so far, led by non-institutional investors. Analysts recommend subscribing mainly for ...

BCCL IPO subscription period runs until January 13, with a potential listing price of ₹33.6, reflecting a 46.09% premium over ...

Hair loss–focused Veradermics and cancer biotech Eikon follow the lead of Aktis Oncology, which last week announced a $318 ...

Amagi Media Labs is launching its IPO for subscription. Early market signs suggest a measured debut rather than a surge. The ...

The shares of Gabion Technologies India made a muted market debut on January 13, listing at Rs 89 per share on the BSE SME ...

Eikon Therapeutics is planning to become the second biotech to go public in 2026, in another sign that the public markets are ...

Not only will an IPO give early backers like Sequoia Capital and TCV a chance to exit, but it means mounting pressure for ...

By now you've heard the news: SpaceX will conduct an initial public offering of stock in 2026 -- at a valuation of $1.5 ...

Discord, the popular chat and community platform, filed confidential IPO paperwork with the SEC and has pinned its hopes on a ...

Gabion Technologies shares started their maiden trading session at ₹89 per share on the BSE SME, against the issue price of ...

Israel Englander, a highly successful hedge fund manager, sold Palantir and bought Tesla in the third quarter.